Prevalence of Hepatitis B and Associated Factors in the Garoua Central Prison, Cameroon: A Cross-Sectional Study
- 1 Faculty of Medicine and Biomedical Sciences, University of Garoua, Garoua, Cameroon
- 2 Faculty of Medicine and Biomedical Sciences, University of Garoua, Garoua, Cameroon
- 3 Faculty of Medicine and Pharmaceutical Sciences, University of Dschang, Dschang, Cameroon
- 4 Faculty de Medicine and Pharmaceutical Sciences, University of Douala, Douala, Cameroon
- 5 Faculty of Health Sciences, University of Buea, Buea, Cameroon
- 6 Faculty of Medicine and Biomedical Sciences, University of Yaoundé 1, Yaoundé, Cameroon
- 7 Faculty of Medicine and Biomedical Sciences, University of Garoua, Garoua, Cameroon
- 8 Faculty of Medicine and Biomedical Sciences, University of Yaoundé 1, Yaoundé, Cameroon
- 9 Faculty of Medicine and Biomedical Sciences, University of Yaoundé 1, Yaoundé, Cameroon
- 10 Faculty de Medicine and Pharmaceutical Sciences, University of Douala, Douala, Cameroon
- 11 Faculty of Medicine and Biomedical Sciences, University of Yaoundé 1, Yaoundé, Cameroon
- 12 Faculty de Medicine and Pharmaceutical Sciences, University of Douala, Douala, Cameroon
- 13 Garoua Regional Hospital, Garoua, Cameroon
Abstract
Introduction : Hepatitis B virus (HBV) infection is a major public health problem in Cameroon. Garoua city is the headquarters of the North Region of Cameroon, where the HBV prevalence is among the highest of the country. The aim of this study was to determine the prevalence of HBsAg carriage and associated factors among persons incarcerated in the Garoua Central Prison. Methods : It was a cross-sectional study conducted from July 1 to July 31, 2023 at the Garoua Central prison. We included all prisoners willing to participate in the study and who gave their verbal consent. We collected data using a pre-established data entry form and we used rapid test for blood screening for HBV surface antigen (HBs Ag) with ELISA confirmation. Data were analyzed using the R ® software for Windows. After the univariate analysis, we selected associated variables to HBV infection with p -value p -value was set at 5%. Results : We included 1389 prisoners out of which 97.6% were male. The median age (IQR) of the study population was 28 (23 - 35) years. The median (IQR) duration of incarceration was 12 (6 - 26) months and the mean (±sd) number of incarcerations was 1.24 (±0.6). HBV prevalence was estimated at 14.8% (95% CI: 13.0 - 16.7). Upon uni- and multivariate analysis, no risk factor was significantly associated with viral hepatitis B infection in our study population. Conclusion : The prevalence of Hepatitis B was high in the Garoua Central Prison, but there were no additional risk factors for HBV infection. There is a need to include the Garoua Central Prison and by the way other prisons in the country in the chronic viral hepatitis care program.
- Bigna, J.J., Amougou, M.A., Asangbeh, S.L., Kenne, A.M., Noumegni, S.R.N., Ngo-Malabo, E.T., et al . (2017) Seroprevalence of Hepatitis B Virus Infection in Cameroon: A Systematic Review and Meta-Analysis. BMJ Open , 7, e015298. https://doi.org/10.1136/bmjopen-2016-015298
- Djapa, N., Roger, G., Galdima, M.A., Ndam, N., Wilson, A., Winnie, N., et al . (2023) Prevalence of Hepatitis B Virus Infection among Adults in Ebolowa, Cameroon. Health Research in Africa , 1, 49-52.
- Djapa, N., Roger, G., Winnie, B., Ndam, N., Wilson, A., Galdima, M., et al . (2023) Prevalence and Risk Factors of Hepatitis B Virus in a Population of Children and Teenagers in Ebolowa, Cameroon: A Community-Based Study. Journal of Gastr o enterology & Digestive Systems , 7, 14-18. https://doi.org/10.33140/JGDS.07.01.02
- Ministère de la Santé Publique (2024) Plan National de Lutte Contre les Hépatites 2024. Plan Stratégique National, 22-23.
- Gétaz, L., Casillas, A., Siegrist, C.-A., Chappuis, F., Togni, G., Tran, N.-T., et al . (2018) Hepatitis B Prevalence, Risk Factors, Infection Awareness and Disease Knowledge among Inmates: A Cross-Sectional Study in Switzerland’s Largest Pre-Trial Prison. Journal of Global Health , 8, Article ID: 020407. https://www.jogh.org https://doi.org/10.7189/jogh.08.020407
- Pierre, K.M., Ankouane, A.F., Tchamdeu, S.D., Wilson, N.N.A., Tangie, N.L., Kouanfack, C., et al . (2021) Seroprevalence of Hepatitis B and Associated Factors among Inmates: A Cross Sectional Study in the Douala New Bell Prison, Cameroon. Pan African Medical Journal , 38, Article No. 355. https://www.panafrican-med-journal.com//content/article/38/355/full https://doi.org/10.11604/pamj.2021.38.355.20386
- Goetz de Gois, J., et al . (2022) Seroprevalence and Factors Associated with Hepatitis B Virus Exposure in the Incarcerated Population from Southern Brazil. PLOS ONE , 17, e0278029. https://doi.org/10.1371/journal.pone.0278029
- Lin, C.-F., Twu, S.-J., Chen, P.-H., Cheng, J.-S. and Wang, J.-D. (2010) Prevalence and Determinants of Hepatitis B Antigenemia in 15007 Inmates in Taiwan Region. Journal of Epidemiology , 20, 231-236. https://doi.org/10.2188/jea.JE20081045
- Weinbaum, C.M., Sabin, K.M. and Santibanez, S.S. (2005) Hepatitis B, Hepatitis C, and HIV in Correctional Populations: A Review of Epidemiology and Prevention. Aids , 19, S41-S46. https://doi.org/10.1097/01.aids.0000192069.95819.aa
- Falla, A.M., Hofstraat, H.I., Duffell, E., Josien, S., Hahné, M., Tavoschi, L., et al . (2018) Hepatitis B/C in the Countries of the EU/ EEA: A Systematic Review of the Prevalence among At-Risk Groups. BMC Infectious Diseases , 18, Article No. 79.